86613156 - NANOPARTICLE DRUG CONJUGATES

Information

• Trademark
• 86613156

• Source

• Serial Number

  86613156

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 28, 2015
  9 years ago

• Transaction Date

  May 05, 2017
  7 years ago

• Status Date

  May 05, 2017
  7 years ago

• Location Date

  May 05, 2017
  7 years ago

• Status Code

  602

• Current Location

  TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  PARK, JENNY K

• Attorney Docket Number

  2003080-0832

  Attorney Name

  Elizabeth A. Walker

  Law Office Assigned Location Code

  L40

• Owners

  • MEMORIAL SLOAN-KETTERING CANCER CENTER

Case File Statements

• GS0051: pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders
• GS0421: research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics

Case File Event Statements

• 5/5/2017 - 7 years ago

  21 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 5/5/2017 - 7 years ago

  20 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 10/7/2016 - 8 years ago

  19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 10/7/2016 - 8 years ago

  18 - FINAL REFUSAL E-MAILED Type: GNFR

• 10/7/2016 - 8 years ago

  17 - FINAL REFUSAL WRITTEN Type: CNFR

• 9/16/2016 - 8 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/16/2016 - 8 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/10/2016 - 8 years ago

  14 - ASSIGNED TO LIE Type: ALIE

• 9/2/2016 - 8 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/4/2016 - 9 years ago

  12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/4/2016 - 9 years ago

  11 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/4/2016 - 9 years ago

  10 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/12/2016 - 9 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/11/2016 - 9 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/11/2016 - 9 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/12/2015 - 9 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/12/2015 - 9 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/12/2015 - 9 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/6/2015 - 9 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/9/2015 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/1/2015 - 9 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP